Drug-eluting coronary stents: insights from preclinical and pathology studies

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease

(2019) Sebastian Kufner et al.   CIRCULATION

Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone

(2019) Ply Chichareon et al.   Expert Review of Medical Devices

Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents

(2019) Sho Torii et al.   EuroIntervention

Direct Targeting of the mTOR (Mammalian Target of Rapamycin) Kinase Improves Endothelial Permeability in Drug-Eluting Stents

(2018) Emanuel Harari et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials

(2018) Sripal Bangalore et al.   CIRCULATION

Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents

(2018) Giulio Guagliumi et al.   EUROPEAN HEART JOURNAL

Restenosis, Stent Thrombosis, and Bleeding Complications

(2018) Juan Torrado et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries

(2018) Sho Torii et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

(2018) Olivier Varenne et al.   LANCET

Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention

(2018) Laura Mauri et al.   AMERICAN HEART JOURNAL

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

(2018) Pascal Vranckx et al.   LANCET

Comparison of Biologic Effect and Particulate Embolization after Femoral Artery Treatment with Three Drug-Coated Balloons in Healthy Swine Model

(2018) Sho Torii et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Predictors of stent thrombosis and their implications for clinical practice

(2018) Tommaso Gori et al.   Nature Reviews Cardiology

Plaque burden influences accurate classification of fibrous cap atheroma by in vivo optical coherence tomography in a porcine model of advanced coronary atherosclerosis

(2018) Christian B. Poulsen et al.   EuroIntervention

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

(2018) Konstantinos Katsanos et al.   Journal of the American Heart Association

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents

(2017) Hiroyoshi Mori et al.   JACC-Cardiovascular Interventions

Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents

(2017) Georges El-Hayek et al.   JACC-Cardiovascular Interventions

Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?

(2017) Antonio Colombo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents

(2017) Anders M. Galløe et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

(2017) David E Kandzari et al.   LANCET

Coronary balloon angioplasty, stents, and scaffolds

(2017) Robert A Byrne et al.   LANCET

Very Late Pathological Responses to Cobalt–Chromium Everolimus‐Eluting, Stainless Steel Sirolimus‐Eluting, and Cobalt–Chromium Bare Metal Stents in Humans

(2017) Hiroyoshi Mori et al.   Journal of the American Heart Association

The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2

(2017) M Watanabe et al.   Oncogenesis

Blood compatibility assessment of polymers used in drug eluting stent coatings

(2016) Luisa Mayorga Szott et al.   Biointerphases

Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence TomographyCLINICAL PERSPECTIVE

(2016) Masanori Taniwaki et al.   CIRCULATION

Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis

(2016) Daisuke Nakamura et al.   Circulation-Cardiovascular Interventions

Stent Coating Integrity of Durable and Biodegradable Coated Drug Eluting Stents

(2016) Saami K. Yazdani et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents

(2016) Lisette Okkels Jensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Additive Value of Integrated Backscatter IVUS for Detection of Vulnerable Plaque by Optical Frequency Domain Imaging

(2016) Masataka Nakano et al.   JACC-Cardiovascular Imaging

Blood compatibility assessment of polymers used in drug eluting stent coatings

(2016) Luisa Mayorga Szott et al.   Biointerphases

Comparison of Vascular Responses Following New‐Generation Biodegradable and Durable Polymer‐Based Drug‐Eluting Stent Implantation in an Atherosclerotic Rabbit Iliac Artery Model

(2016) Gaku Nakazawa et al.   Journal of the American Heart Association

The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study

(2015) Gregory J. Wilson et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Hypersensitivity Reaction in the US Food and Drug Administration-Approved Second-Generation Drug-Eluting Stents: Histopathological Assessment With Ex Vivo Optical Coherence Tomography

(2015) F. Otsuka et al.   CIRCULATION

Simultaneous Intravascular Ultrasound Usage Overcomes Misinterpretation When Evaluating Lipid-Rich Plaques With Optical Frequency Domain Imaging　– Ex Vivo Study –

(2015) Sho Torii et al.   CIRCULATION JOURNAL

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

(2015) Fumiyuki Otsuka et al.   EUROPEAN HEART JOURNAL

Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model

(2015) Fumiyuki Otsuka et al.   JACC-Cardiovascular Interventions

Long-Term Safety of Drug-Eluting and Bare-Metal Stents

(2015) Tullio Palmerini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Accuracy of OCT, Grayscale IVUS, and Their Combination for the Diagnosis of Coronary TCFA

(2015) Kenichi Fujii et al.   JACC-Cardiovascular Imaging

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

(2015) E. P. Navarese et al.   BMJ-British Medical Journal

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

(2015) E. P. Navarese et al.   BMJ-British Medical Journal

Impact of stent strut design in metallic stents and biodegradable scaffolds

(2014) Nicolas Foin et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Risks and benefits of extended DAPT after stenting

(2014) Karina Huynh   Nature Reviews Cardiology

Longitudinal compression behaviour of coronary stents: a bench-top comparative study

(2014) Paul Barragan et al.   EuroIntervention

Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model

(2014) Gaku Nakazawa et al.   EuroIntervention

New stent surface materials: The impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets

(2013) Raila Busch et al.   Acta Biomaterialia

Closed versus open cell stent for high-risk percutaneous coronary interventions in ST-elevation acute myocardial infarction: The Closed versus Open Cells stent for High risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot study

(2013) Alessandro Sciahbasi et al.   AMERICAN HEART JOURNAL

Sirolimus-FKBP12.6 Impairs Endothelial Barrier Function Through Protein Kinase C-α Activation and Disruption of the p120–Vascular Endothelial Cadherin Interaction

(2013) Anwer Habib et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The effects of stenting on shear stress: relevance to endothelial injury and repair

(2013) Kim Van der Heiden et al.   CARDIOVASCULAR RESEARCH

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

(2013) Fumiyuki Otsuka et al.   CIRCULATION

Impact of Stent Surface on Thrombogenicity and Vascular Healing

(2013) Michael J. Eppihimer et al.   Circulation-Cardiovascular Interventions

New concepts in the design of drug-eluting coronary stents

(2013) Scot Garg et al.   Nature Reviews Cardiology

Modeling Stented Coronary Arteries: Where We are, Where to Go

(2012) Stefano Morlacchi et al.   ANNALS OF BIOMEDICAL ENGINEERING

Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion/incomplete apposition during PCI

(2012) N. Foin et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Recent advances in drug eluting stents

(2012) Amey S. Puranik et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Primary Endpoint Results of the EVOLVE Trial

(2012) Ian T. Meredith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

(2012) Tullio Palmerini et al.   LANCET

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

(2012) Manel Sabate et al.   LANCET

Delayed Coverage in Malapposed and Side-Branch Struts With Respect to Well-Apposed Struts in Drug-Eluting Stents

(2011) Juan Luis Gutiérrez-Chico et al.   CIRCULATION

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Stent Longitudinal Integrity

(2011) John A. Ormiston et al.   JACC-Cardiovascular Interventions

The Pathology of Neoatherosclerosis in Human Coronary Implants

(2011) Gaku Nakazawa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

(2011) Gaku Nakazawa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Polymer-Free Biolimus A9-Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model

(2010) Norio Tada et al.   Circulation-Cardiovascular Interventions

Everolimus

(2010) P. J. Houghton   CLINICAL CANCER RESEARCH

A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents

(2010) Josep Gomez-Lara et al.   JACC-Cardiovascular Interventions

Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries

(2009) Gregory J. Wilson et al.   CIRCULATION